Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance

BACKGROUND: Serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) complements nucleic acid tests for patient diagnosis and enables monitoring of population susceptibility to inform the coronavirus disease 2019 (COVID-19) pandemic response. It is important to understand...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Open Forum Infect Dis
Autors principals: Nicholson, Suellen, Karapanagiotidis, Theo, Khvorov, Arseniy, Douros, Celia, Mordant, Francesca, Bond, Katherine, Druce, Julian, Williamson, Deborah A, Purcell, Damian, Lewin, Sharon R, Sullivan, Sheena, Subbarao, Kanta, Catton, Mike
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2021
Matèries:
Major Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8136026/
https://ncbi.nlm.nih.gov/pubmed/34258311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofab239
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars